Growth Metrics

Heron Therapeutics (HRTX) Amortizatization of Intangibles: 2011-2025

Historic Amortizatization of Intangibles for Heron Therapeutics (HRTX) over the last 11 years, with Sep 2025 value amounting to $130,000.

  • Heron Therapeutics' Amortizatization of Intangibles fell 76.06% to $130,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 55.22%. This contributed to the annual value of $2.1 million for FY2024, which is 23.23% up from last year.
  • According to the latest figures from Q3 2025, Heron Therapeutics' Amortizatization of Intangibles is $130,000, which was down 45.61% from $239,000 recorded in Q2 2025.
  • In the past 5 years, Heron Therapeutics' Amortizatization of Intangibles registered a high of $638,000 during Q1 2024, and its lowest value of -$104,000 during Q1 2022.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $389,000 (2024), whereas its average is $412,000.
  • In the last 5 years, Heron Therapeutics' Amortizatization of Intangibles slumped by 120.72% in 2022 and then skyrocketed by 3,181.82% in 2023.
  • Over the past 5 years, Heron Therapeutics' Amortizatization of Intangibles (Quarterly) stood at $283,000 in 2021, then crashed by 96.11% to $574,000 in 2022, then declined by 1.39% to $566,000 in 2023, then plummeted by 31.27% to $389,000 in 2024, then tumbled by 76.06% to $130,000 in 2025.
  • Its Amortizatization of Intangibles stands at $130,000 for Q3 2025, versus $239,000 for Q2 2025 and $281,000 for Q1 2025.